James Healy's Net Worth

$17.1 Million

Estimate Recalculated Sep 29, 2025 08:01PM EST

Who is James Healy

James Healy has an estimated net worth of $17.1 Million. This is based on reported shares across multiple companies, which include Natera, Inc., ArriVent Biopharma, Inc., , AMARIN CORP PLC\UK, COTHERIX INC, Trius Therapeutics Inc, HYPERION THERAPEUTICS INC, Y-mAbs Therapeutics, Inc., MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Vera Therapeutics, Inc., Aclaris Therapeutics, Inc., Karuna Therapeutics, Inc., Aerovate Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Coherus BioSciences, Inc., Edge Therapeutics, Inc., Inozyme Pharma, Inc., KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., Bolt Biotherapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., THRESHOLD PHARMACEUTICALS INC, aTYR PHARMA INC, ALIMERA SCIENCES INC, Akouos, Inc., NOVACEA INC, Durata Therapeutics, Inc., Versartis, Inc., Anthera Pharmaceuticals Inc, Spark Therapeutics, Inc., Ocera Therapeutics, Inc., ANESIVA, INC., INTERMUNE INC, and Rapport Therapeutics, Inc..

SEC CIK

James Healy's CIK is 0001245624

Past Insider Trading and Trends

2022 was James Healy's most active year for acquiring shares with 14 total transactions. James Healy's most active month to acquire stocks was the month of April. 2014 was James Healy's most active year for disposing of shares, totalling 15 transactions. James Healy's most active month to dispose stocks was the month of December. 2022 saw James Healy paying a total of $951,227.38 for 200,024 shares, this is the most they've acquired in one year. In 2024 James Healy cashed out on 61,394 shares for a total of $16,984,679.20, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMARIN CORP PLC\UK

Investor
Updated Jul 13, 2016
Form 4
49.40K
Jul 13, 2016
49.40K
Grant
Jul 11
Form 4
38.87M
$0.15
$5.83M
Jul 14, 2015
38.87M
Grant
Jul 10
Form 4
99.00K
Jul 08, 2015
99.00K
Grant
Jul 06
Form 4
52.50K
Mar 13, 2014
52.50K
Grant
Mar 11
Form 4
22.50K
Jul 11, 2013
22.50K
Grant
Jul 09
Form 4
$1.03
$30.90K
Sep 05, 2012
6.44M
Options
Aug 31
Form 4
$1.50
$1.21M
Aug 15, 2012
6.38M
Options
Aug 14
Form 4
30.00K
Jul 13, 2012
30.00K
Grant
Jul 10
Form 4
-53.82%
-941.80K
$9.03
-$8.51M
Apr 06, 2012
808.20K
Sale
Apr 04
Form 4
-26.62%
-2.00M
$10.98
-$21.96M
Apr 04, 2012
5.51M
Sale
Apr 02 - Apr 03
Form 4
-11.75%
-1.00M
$10.98
-$10.98M
Mar 30, 2012
7.51M
Sale
Mar 28 - Mar 29
Form 4
$1.03
$61.80K
Jan 31, 2012
120.00K
Options
Jan 27
Form 4
-4.75%
-424.90K
$7.25
-$3.08M
Mar 31, 2011
8.51M
Sale
Mar 29
Form 4
-6.05%
-575.10K
$7.55
-$4.34M
Mar 28, 2011
8.94M
Sale
Mar 24 - Mar 25
Form 4
-17.37%
-2.00M
$7.50
-$15.00M
Mar 14, 2011
9.51M
Sale
Mar 11
Form 4
-5.24%
-637.00K
$7.26
-$4.62M
Mar 11, 2011
11.51M
Sale
Mar 09 - Mar 10
Form 4
-2.90%
-363.00K
$8.13
-$2.95M
Mar 01, 2011
12.15M
Sale
Feb 25
Form 3
Dec 30, 2010
12.51M
Showing 18 results

COTHERIX INC

Investor
Updated Jan 10, 2007
Form 4
-100.00%
-2.43M
$7.50
-$32.38M
Jan 10, 2007
Disposition
Jan 09
Form 4
9.09K
Jan 05, 2007
9.09K
Grant
Jan 03
Form 4
9.09K
Jan 19, 2006
9.09K
Grant
Jan 03
Form 4
6.06K
Jan 03, 2005
6.06K
Grant
Jan 03
Form 4
5.15%
115.78K
Oct 21, 2004
2.40M
Options
Oct 20
Form 4
252.10%
358.43K
$6.00
$2.15M
Oct 19, 2004
539.99K
Purchase
Oct 15
Form 3
Oct 15, 2004
181.57K
Showing 7 results

HYPERION THERAPEUTICS INC

Investor
Updated May 08, 2015
Form 4
-100.00%
-1.97M
$46.00
-$90.43M
May 08, 2015
Disposition
May 04 - May 07
Form 4
-17.72%
-417.75K
$27.70
-$11.57M
Jun 06, 2014
1.95M
Sale
Jun 04
Form 4
63.15%
7.49K
May 29, 2014
2.38M
Grant
May 27
Form 4
-20.02%
-590.00K
$30.02
-$709.22K
Mar 05, 2014
2.37M
Sale
ScheduledMar 03 - Mar 04
Form 4
9.80K
May 01, 2013
9.80K
Grant
Apr 15
Form 4
18.73%
408.39K
$10.00
-$1.03M
Aug 02, 2012
2.96M
Purchase
Jul 31
Form 3
Jul 25, 2012
15.79K
Showing 7 results

MARINUS PHARMACEUTICALS INC

Investor
Updated Oct 24, 2016
Form 4
-35.31%
-750.68K
$1.39
-$1.04M
Oct 24, 2016
1.38M
Sale
Oct 20
Form 4
-59.41%
-7.45M
$8.00
$6.01M
Aug 07, 2014
5.09M
Buy-Options
Aug 05
Form 3
Jul 31, 2014
Showing 3 results

HISTOGENICS CORP

Investor
Updated Dec 10, 2014
Form 4
30.91%
490.39K
$10.86
Dec 10, 2014
2.08M
Purchase
Dec 08
Form 3
Dec 02, 2014
Showing 2 results

Vera Therapeutics, Inc.

Investor
Updated Feb 08, 2023
Form 4
8.98%
285.71K
$7.00
$2.00M
Feb 08, 2023
3.47M
Purchase
Feb 06
Form 4
9.15%
266.67K
$15.00
$4.00M
Feb 14, 2022
3.18M
Purchase
Feb 10
Form 4
33.25%
727.27K
$11.00
May 18, 2021
2.91M
Purchase
May 18
Form 3
May 13, 2021
Showing 4 results

Aclaris Therapeutics, Inc.

Investor
Updated Oct 13, 2015
Form 4
-64.71%
-4.20M
$11.00
Oct 13, 2015
2.29M
Buy-Options
Oct 13
Form 3
Oct 06, 2015
Showing 2 results

AERIE PHARMACEUTICALS INC

Investor
Updated Jul 11, 2014
Form 4
-39.15%
-1.01M
$24.91
-$24.21M
Jul 11, 2014
1.57M
Sale
Jul 09 - Jul 10
Form 4
-6.94%
-191.98K
Jun 04, 2014
2.57M
Disposition
Jun 02
Form 4
-10.48%
-323.93K
$16.00
-$5.18M
May 27, 2014
2.77M
Sale
May 22
Form 4
-75.75%
-10.12M
$6.49
Oct 30, 2013
3.24M
Buy-Options
Oct 25
Form 3
Oct 25, 2013
Showing 5 results

Inozyme Pharma, Inc.

Investor
Updated Jul 28, 2020
Form 4
-82.94%
-9.86M
$16.00
Jul 28, 2020
2.03M
Buy-Options
Jul 28
Form 3
Jul 23, 2020
Showing 2 results

KALOBIOS PHARMACEUTICALS INC

Investor
Updated May 02, 2013
Form 4
15.00K
May 02, 2013
15.00K
Grant
Apr 30
Form 4
0.63%
57.16K
Feb 07, 2013
9.57M
Options
Feb 05
Form 4
4,699.84%
375.00K
$8.00
$3.00M
Feb 04, 2013
382.98K
Purchase
Jan 31
Form 3
Aug 10, 2012
28.42K
Showing 4 results

Entasis Therapeutics Holdings Inc.

Investor
Updated Oct 02, 2018
Form 4
-91.12%
-15.79M
$15.00
Oct 02, 2018
1.54M
Buy-Options
Sep 28
Form 3
Sep 25, 2018
Showing 2 results

Checkmate Pharmaceuticals, Inc.

Investor
Updated Aug 12, 2020
Form 4
-85.51%
-21.29M
$15.00
Aug 12, 2020
3.61M
Buy-Options
Aug 11
Form 3
Aug 06, 2020
Showing 2 results

Galera Therapeutics, Inc.

Investor
Updated Nov 12, 2019
Form 4
-73.87%
-8.72M
$12.00
Nov 12, 2019
3.08M
Buy-Options
Nov 12
Form 3
Nov 06, 2019
Showing 2 results

Principia Biopharma Inc.

Investor
Updated Sep 20, 2018
Form 4
15.27%
270.00K
$17.00
Sep 20, 2018
2.06M
Purchase
Sep 18
Form 3
Sep 13, 2018
Showing 2 results

NextCure, Inc.

Investor
Updated Nov 19, 2019
Form 4
5.95%
150.00K
$36.75
$5.51M
Nov 19, 2019
2.67M
Purchase
Nov 15
Form 4
-85.21%
-14.52M
$15.00
May 15, 2019
2.52M
Buy-Options
May 13
Form 3
May 08, 2019
Showing 3 results

THRESHOLD PHARMACEUTICALS INC

Investor
Updated Feb 10, 2005
Form 4
7.30%
234.00K
$7.00
$1.64M
Feb 10, 2005
3.44M
Purchase
Feb 09
Form 3
Feb 03, 2005
Showing 2 results

aTYR PHARMA INC

Investor
Updated May 14, 2015
Form 4
-87.53%
-13.10M
$14.00
May 14, 2015
1.87M
Buy-Options
May 12
Form 3
May 06, 2015
Showing 2 results

ALIMERA SCIENCES INC

Investor
Updated Sep 15, 2014
Form 4
151.85%
379.62K
$2.66
$6.67M
Sep 15, 2014
629.62K
Options
Sep 11 - Sep 12
Form 3
Oct 04, 2012
Showing 2 results

Akouos, Inc.

Investor
Updated Jul 01, 2020
Form 4
-95.06%
-29.17M
$17.00
Jul 01, 2020
1.52M
Buy-Options
Jun 30
Form 3
Jun 25, 2020
Showing 2 results

NOVACEA INC

Investor
Updated Mar 31, 2008
Form 4/A
20.00K
Mar 31, 2008
20.00K
Grant
Feb 13
Form 4
-50.00%
-12.50K
Feb 19, 2008
12.50K
Grant
Feb 13
Form 4
12.50K
Jan 19, 2007
2.27M
Grant
Jan 17
Form 4
22.00%
400.00K
$6.50
$2.60M
May 15, 2006
2.26M
Purchase
May 15
Form 3
May 09, 2006
43.21K
Showing 5 results

Durata Therapeutics, Inc.

Investor
Updated Jul 25, 2012
Form 4
17.47%
588.24K
$9.00
$5.29M
Jul 25, 2012
3.96M
Purchase
Jul 24
Form 3
Jul 19, 2012
6.25K
Showing 2 results

Versartis, Inc.

Investor
Updated Mar 28, 2014
Form 4
2.87%
60.00K
$21.00
Mar 28, 2014
2.15M
Purchase
Mar 26
Form 3
Mar 20, 2014
Showing 2 results

Anthera Pharmaceuticals Inc

Investor
Updated Dec 22, 2011
Form 4/A
13.50%
2.10M
$6.13
$12.56M
Dec 22, 2011
17.66M
Options
Mar 04
Form 3/A
Dec 22, 2011
Form 3
Feb 23, 2010
20.44K
Showing 3 results

Spark Therapeutics, Inc.

Investor
Updated Jan 29, 2015
Form 3
Jan 29, 2015
Showing 1 results

Iterum Therapeutics plc

Investor
Updated Jun 03, 2020
Form 4
-28.96%
-500.00K
$1.62
-$812.08K
Jun 03, 2020
1.23M
Sale
Jun 01 - Jun 02
Form 4
1.75M
$1.00
$1.75M
Jan 23, 2020
1.75M
Grant
Jan 21
Form 4
-50.00%
-5.70K
Jun 17, 2019
5.70K
Grant
Jun 13
Form 4
May 29, 2019
1.73M
Options
May 24
Form 4
40.77%
500.00K
$13.00
May 30, 2018
1.73M
Purchase
May 30
Form 4
6.15K
May 29, 2018
6.15K
Grant
May 24
Form 3
May 24, 2018
Showing 7 results

Natera, Inc.

Investor
Updated Oct 29, 2024
Form 4
0.33%
153.00
Oct 29, 2024
1.60M
Grant
Oct 25
Form 4
0.39%
177.00
Jul 30, 2024
1.60M
Grant
Jul 26
Form 4
6.94%
2.96K
Jul 02, 2024
1.60M
Grant
Jun 28
Form 4
0.49%
210.00
Apr 30, 2024
1.59M
Grant
Apr 26
Form 4
0.63%
264.00
$63.79
$16.84K
Jan 30, 2024
1.59M
Grant
Jan 26
Form 4
-100.00%
-644.00K
$58.75
-$37.83M
Dec 22, 2023
1.59M
Sale
Dec 13
Form 4
0.95%
396.00
$42.60
$16.87K
Oct 31, 2023
3.14M
Grant
Oct 27
Form 4
0.79%
328.00
$48.48
$15.90K
Aug 01, 2023
3.14M
Grant
Jul 28
Form 4
18.07%
7.00K
Jul 05, 2023
3.15M
Grant
Jun 30
Form 4
May 30, 2023
3.14M
Options
May 25
Form 4
0.82%
285.00
$54.73
$15.60K
Apr 18, 2023
3.14M
Grant
Apr 14
Form 4
1.13%
390.00
$40.01
$15.60K
Jan 18, 2023
3.14M
Grant
Jan 13
Form 4
-100.00%
-2.40K
$37.71
-$90.50K
Jan 18, 2023
3.14M
Sale
Nov 16
Form 4
1.01%
344.00
$45.42
$15.62K
Oct 18, 2022
3.14M
Grant
Oct 14
Form 4/A
1.27%
430.00
Sep 02, 2022
34.21K
Grant
Jul 08
Form 4
430.00
$36.31
$15.61K
Jul 12, 2022
430.00
Grant
Jul 08
Form 4
10.60K
Jun 01, 2022
10.60K
Grant
May 27
Form 4
May 27, 2022
3.14M
Options
May 25
Form 4
2.40K
$113.00
$271.20K
Jul 26, 2021
3.14M
Purchase
Jul 22
Form 4
12.08%
3.92K
Jun 02, 2021
3.14M
Options
May 28
Form 4
8.57K
Jun 16, 2020
8.57K
Grant
Jun 12
Form 4
$11.11
$248.06K
Jan 14, 2020
3.13M
Options
Jan 10
Form 4
Nov 27, 2019
3.11M
Options
May 16
Form 4
22.00K
May 29, 2019
22.00K
Grant
May 24
Form 4
7.28K
Apr 16, 2019
7.28K
Grant
Apr 12
Form 4/A
5.79K
Apr 16, 2019
Grant
Sep 14
Form 4
16.95K
Sep 18, 2018
16.95K
Grant
Sep 14
Form 4
11.17K
Jun 13, 2017
11.17K
Grant
Jun 09
Form 4
11.17K
Jun 14, 2016
11.17K
Grant
Jun 10
Form 4
12.72%
350.00K
$18.00
Jul 09, 2015
3.10M
Purchase
Jul 08
Form 4
400.00K
$22.81
$9.12M
Jul 07, 2015
400.00K
Purchase
Jul 02
Form 3
Jul 01, 2015
Showing 32 results

ArriVent Biopharma, Inc.

Investor
Updated Jan 31, 2024
Form 4
35.49%
444.44K
$18.00
Jan 31, 2024
1.70M
Purchase
Jan 30
Form 3
Jan 25, 2024
Showing 2 results

Investor
Updated Feb 27, 2023
Form 4
-100.00%
-6.11M
$14.32
-$85.92K
Feb 27, 2023
Sale
Nov 28 - Feb 24
Form 4
9.08%
506.00K
$30.00
$15.18M
Aug 15, 2022
6.11M
Purchase
Aug 11
Form 4
$13.60
$399.99K
Aug 08, 2022
5.60M
Options
Aug 05
Form 4
-68.77%
-12.27M
$16.00
Jan 13, 2022
5.57M
Buy-Options
Jan 11
Form 3
Jan 06, 2022
Showing 5 results

Trius Therapeutics Inc

Investor
Updated Jan 17, 2012
Form 4
-96.00%
-3.47M
Jan 17, 2012
144.65K
Disposition
ScheduledJan 12
Form 4/A
-77.78%
-12.66M
$4.68
Aug 18, 2010
3.62M
Buy-Options
Aug 06
Form 3/A
Aug 18, 2010
Showing 3 results

Y-mAbs Therapeutics, Inc.

Investor
Updated Jun 13, 2024
Form 4
64.18%
18.04K
Jun 13, 2024
2.24M
Grant
Jun 11
Form 4
63.15%
16.28K
Jun 09, 2023
2.24M
Grant
Jun 08
Form 4
16.00K
Jul 19, 2022
16.00K
Grant
Jul 15
Form 4
16.00K
Jun 14, 2021
16.00K
Grant
Jun 10
Form 4
16.00K
Jun 24, 2020
16.00K
Grant
Jun 23
Form 4
$14.35
$370.00K
Jan 17, 2020
2.27M
Options
Jan 15
Form 4
4.28%
90.00K
$28.00
$2.52M
Nov 01, 2019
2.19M
Purchase
Oct 30
Form 4
16.00K
Jun 14, 2019
16.00K
Grant
Jun 12
Form 4
31.17%
500.00K
$16.00
$8.00M
Sep 25, 2018
2.10M
Purchase
Sep 21
Form 3
Sep 20, 2018
1.60M
Showing 10 results

Karuna Therapeutics, Inc.

Investor
Updated Mar 18, 2024
Form 4
-100.00%
-1.44M
$259.22
-$472.76M
Mar 18, 2024
Disposition
Mar 18
Form 4
8.90%
2.89K
Jun 22, 2023
1.42M
Grant
Jun 20
Form 4
-22.11%
-391.98K
Jun 20, 2023
1.41M
Disposition
Jun 14
Form 4
-14.48%
-300.00K
$199.90
-$1.20M
Jan 17, 2023
1.81M
Sale
Jan 12 - Jan 13
Form 4
$16.00
$520.00K
Aug 08, 2022
2.11M
Options
Aug 05
Form 4
6.15%
120.00K
$122.80
$14.74M
Jul 01, 2022
2.07M
Purchase
Jun 29 - Jun 30
Form 4
5.00K
Jun 16, 2022
5.00K
Grant
Jun 15
Form 4
7.39%
47.00
$129.38
$6.08K
Apr 14, 2022
1.95M
Purchase
Apr 01
Form 4
636.00
$117.80
$74.92K
Jul 07, 2021
636.00
Purchase
Jul 02
Form 4
8.50K
Jun 23, 2021
8.50K
Grant
Jun 16
Form 4
0.23%
4.56K
$73.75
$336.08K
Sep 11, 2020
1.95M
Purchase
Sep 09
Form 4
3.30%
62.28K
$71.74
$4.47M
Sep 09, 2020
1.95M
Purchase
Sep 04 - Sep 08
Form 4
12.50K
Jun 08, 2020
12.50K
Grant
Jun 04
Form 4
9.04%
156.25K
$96.00
$15.00M
Nov 25, 2019
1.89M
Purchase
Nov 25
Form 4
118.19%
936.75K
$16.00
Jul 02, 2019
1.73M
Purchase
Jul 02
Form 4
32.50K
Jul 01, 2019
32.50K
Grant
Jun 27
Form 3
Jun 27, 2019
Showing 17 results

Aerovate Therapeutics, Inc.

Investor
Updated Jul 06, 2021
Form 4
-64.42%
-6.81M
$14.00
Jul 06, 2021
3.76M
Buy-Options
Jul 02
Form 3
Jun 29, 2021
Showing 2 results

Coherus BioSciences, Inc.

Investor
Updated Feb 11, 2022
Form 4/A
27.00K
Feb 11, 2022
27.00K
Grant
Jan 07
Form 4
27.00K
Jan 10, 2022
27.00K
Grant
Jan 07
Form 4
-100.00%
-434.56K
$16.68
-$7.25M
Sep 29, 2021
70.09K
Sale
Sep 27 - Sep 29
Form 4
20.00K
Jan 13, 2021
20.00K
Grant
Jan 11
Form 4
-62.89%
-736.45K
Oct 01, 2020
504.64K
Disposition
Sep 29
Form 4
-39.43%
-762.21K
Sep 01, 2020
1.24M
Disposition
Aug 28
Form 4
20.00K
Jan 14, 2020
20.00K
Grant
Jan 10
Form 4
$7.12
$498.40K
Jan 13, 2020
2.00M
Options
Jan 09 - Jan 12
Form 4
-15.70%
-360.00K
$22.30
-$8.03M
Jul 02, 2019
1.93M
Sale
ScheduledJun 28 - Jul 02
Form 4
-12.15%
-317.13K
$21.37
-$6.78M
Jun 24, 2019
2.29M
Sale
ScheduledJun 20
Form 4
-8.99%
-257.87K
$20.69
-$5.34M
May 24, 2019
2.61M
Sale
ScheduledMay 22
Form 4
20.00K
Jan 30, 2019
2.89M
Grant
Jan 11
Form 4
-0.86%
-25.00K
$20.50
-$512.50K
Aug 31, 2018
2.87M
Sale
ScheduledAug 29
Form 4
20.00K
Feb 05, 2018
2.91M
Grant
Feb 01
Form 4
20.00K
May 19, 2017
2.91M
Grant
May 17
Form 4
10.00K
May 26, 2016
2.90M
Grant
May 24
Form 4/A
14.88%
380.51K
May 27, 2015
2.94M
Acquisition
Mar 10 - Apr 01
Form 4
14.88%
380.51K
Apr 03, 2015
2.94M
Acquisition
Mar 10 - Apr 01
Form 4
19.98%
425.93K
$13.50
Nov 12, 2014
2.56M
Purchase
Nov 12
Form 3
Nov 06, 2014
134.97K
Showing 20 results

Edge Therapeutics, Inc.

Investor
Updated Jun 21, 2017
Form 4
15.00K
$10.15
$152.25K
Jun 21, 2017
15.00K
Grant
Jun 20
Form 4
15.00K
Jun 23, 2016
15.00K
Grant
Jun 21
Form 4
23.42%
541.34K
$7.30
$3.95M
Mar 15, 2016
2.85M
Purchase
Mar 11
Form 4
-6.54%
-161.75K
$10.74
Oct 08, 2015
2.31M
Buy-Options
Oct 06
Form 3
Sep 30, 2015
Showing 5 results

Bolt Biotherapeutics, Inc.

Investor
Updated Jun 14, 2024
Form 4
22.00K
Jun 14, 2024
22.00K
Grant
Jun 12
Form 4
25.00K
Jun 14, 2023
25.00K
Grant
Jun 12
Form 4
25.00K
Jun 10, 2022
25.00K
Grant
Jun 10
Form 4
25.00K
Mar 28, 2022
25.00K
Grant
Mar 24
Form 4
19.53%
450.00K
$20.00
Feb 09, 2021
2.75M
Purchase
Feb 09
Form 3
Feb 04, 2021
Showing 6 results

Mirna Therapeutics, Inc.

Investor
Updated Oct 06, 2015
Form 4
62.75%
1.15M
$7.00
Oct 06, 2015
2.97M
Purchase
Oct 05 - Oct 06
Form 3
Sep 30, 2015
Showing 2 results

Ocera Therapeutics, Inc.

Investor
Updated Mar 20, 2014
Form 4
-33.00%
-410.02K
Mar 20, 2014
832.47K
Disposition
Mar 18
Form 3
Jul 17, 2013
851.33K
Form 4
45.95%
391.17K
$6.03
$2.36M
Jul 17, 2013
1.24M
Purchase
Jul 15
Showing 3 results

ANESIVA, INC.

Investor
Updated Dec 21, 2007
Form 3/A
Dec 21, 2007
4.91M
Form 3
Dec 18, 2007
4.91M
Showing 2 results

INTERMUNE INC

Investor
Updated Oct 02, 2014
Form 4
-100.00%
-145.88K
$74.00
-$1.00M
Oct 02, 2014
Disposition
Sep 29
Form 4
88.57%
12.00K
Jun 03, 2014
25.55K
Options
May 29 - May 30
Form 4
9.00K
Jun 03, 2013
9.00K
Grant
May 30
Form 4
127.82%
8.50K
$10.10
$25.25K
Jun 06, 2012
15.15K
Grant
Jun 04
Form 4
12.00K
May 12, 2011
12.00K
Grant
May 10
Form 4
-37.58%
-2.50K
Jan 03, 2011
4.15K
Grant
Dec 29
Form 4
6.84%
12.00K
May 10, 2010
187.39K
Grant
May 10
Form 4
$4.50
$22.50K
Jan 27, 2010
6.65K
Options
Jan 26
Form 4
6.80%
12.00K
Jun 24, 2009
188.39K
Grant
May 21
Form 4
7.67%
12.00K
May 15, 2008
168.39K
Grant
May 13
Form 4
8.31%
12.00K
May 17, 2007
156.39K
Grant
May 15
Form 4
16.08%
20.00K
May 25, 2006
144.39K
Grant
May 25
Form 4
-82.06%
-7.54K
$19.27
-$145.31K
Mar 03, 2006
1.65K
Sale
Mar 03
Form 4
-52.11%
-10.00K
$19.61
-$196.05K
Mar 03, 2006
9.19K
Sale
Mar 02
Form 4
-20.67%
-5.00K
$19.10
-$95.50K
Feb 24, 2006
19.19K
Sale
Feb 24
Form 4
-38.28%
-15.00K
$18.88
-$283.25K
Feb 23, 2006
24.19K
Sale
Feb 22 - Feb 23
Form 4
-2.59%
-2.00K
Nov 16, 2005
75.13K
Grant
Nov 14
Form 4
16.90%
20.00K
May 31, 2005
138.34K
Grant
May 27
Form 4
8.34K
Jan 04, 2005
8.34K
Grant
Jan 01
Form 4
25.00K
Jan 05, 2004
25.00K
Grant
Jan 02
Showing 20 results

Rapport Therapeutics, Inc.

Investor
Updated Jul 03, 2024
Form 4
63.27%
44.03K
$24.52
$1.08M
Jul 03, 2024
2.00M
Purchase
Jul 01
Form 4
-83.63%
-9.97M
$17.00
$9.50M
Jun 10, 2024
1.95M
Buy-Options
Jun 10
Form 3
Jun 06, 2024
Showing 3 results

BioAge Labs, Inc.

Investor
Updated Sep 27, 2024
Form 4
-68.27%
-4.99M
$18.00
$1.40M
Sep 27, 2024
2.32M
Buy-Options
Sep 25 - Sep 27
Showing 1 results